TScan Therapeutics, Inc. (TCRX) Reports Q1 2026 Results With Improved Net Loss
We recently compiled a list of the 10 Popular Penny Stocks on Robinhood to Watch in 2026. TScan Therapeutics, Inc. (NASDAQ:TCRX) is one of the most popular penny stocks.
Tscan Therapeutics Inc. (TCRX)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,208,199 | $379,979 | -9% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.90 | 6,232 | $5,601.94 | 8,019,148 | 2025-12-23 | Filing | |
| $0.90 | 75,500 | $67,950.00 | 8,012,916 | 2025-12-22 | Filing | |
| $0.90 | 80,069 | $71,974.02 | 7,937,416 | 2025-12-19 | Filing | |
| $1.20 | 1,200,000 | $1,440,000.00 | 7,946,141 | 2025-05-20 | Filing | |
| $1.20 | 1,388,794 | $1,666,552.80 | 6,746,141 | 2025-05-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.78 | 164,686 | $952,115.64 | 4,716 | 2024-08-23 | Filing | |
| $2.51 | 400 | $1,003.00 | 5,224,600 | 2023-05-31 | Filing | |
| $2.52 | 15,000 | $37,801.50 | 5,225,000 | 2023-05-31 | Filing | |
| $2.51 | 10,000 | $25,148.00 | 5,240,000 | 2023-05-31 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 604,332 | $190,136 | 0% | |
| 2. | 108,247 | $34,098 | 0% | |
| 3. | 95,875 | $30,153 | 0% | |
| 4. | 62,525 | $19,664 | 0% | |
| 5. | 21,607 | $6,796 | 0% |
News See All
10 Popular Penny Stocks on Robinhood to Watch in 2026
In this article, we will be taking a look at the 10 Popular Penny Stocks on Robinhood to Watch in 2026.
Strong Analyst Sentiment on TScan Therapeutics (TCRX) Amid Ongoing Momentum in Cell Therapy Space
TScan Therapeutics, Inc. (NASDAQ:TCRX) is among the top 10 stocks under $5 that could triple.
Top 10 Stocks Under $5 That Could Triple
In this piece, we discuss the Top 10 Stocks Under $5 That Could Triple.
Chinese Billionaire Zhang Lei is Selling These 10 Stocks
In this article, we present the list of the 1o stocks that billionaire Zhang Lei is selling off. Zhang Lei is the CEO and founder of Hillhouse Capital Management.
Hedge Fund Resource Center